South Korea has signed contracts with Pfizer and Johnson & Johnson’s pharmaceutical company Janssen to import Covid-19 vaccines, Prime Minister Chung Sye-kyun said in a briefing on Thursday.
According to the contract, South Korea will import doses for 6 million people from Janssen, 2 million more than announced in early December. Vaccination using Janssen's doses will begin in the second quarter of 2021, Chung added.
South Korea will also import vaccine doses for 10 million people from Pfizer in the third quarter of 2021, Chung said. Chung added that the government is making all possible efforts to bring in the Pfizer vaccine in the second quarter of next year.
Previously, South Korea announced that it had signed a contract with vaccine developer AstraZeneca to import vaccines for 10 million people starting in the first quarter of 2021. The government said it would also import vaccine doses for 10 million people from Moderna and additional doses for 10 million people through Covax Facility.
South Korea is home to around 52 million people.
The situation in South Korea: The East Asian country recorded 955 local and 30 imported Covid-19 cases Wednesday, of which 644 were from the Seoul metropolitan area, Korea Disease Control and Prevention Agency (KDCA) said in a news release on Thursday. An additional 17 deaths were reported Wednesday.
The latest numbers brings the total tally of cases since the start of the pandemic to 53,533, including 756 deaths.